<i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina

Background: Coronary artery disease is caused by changes in the coronary arteries due to the atherosclerotic process and thrombotic changes. A very important role in the development of the atherosclerotic process in the coronary vessels is played by the inflammatory process and the immune response....

Full description

Bibliographic Details
Main Authors: Damian Malinowski, Krzysztof Safranow, Andrzej Pawlik
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/14/2/213
_version_ 1797297755417214976
author Damian Malinowski
Krzysztof Safranow
Andrzej Pawlik
author_facet Damian Malinowski
Krzysztof Safranow
Andrzej Pawlik
author_sort Damian Malinowski
collection DOAJ
description Background: Coronary artery disease is caused by changes in the coronary arteries due to the atherosclerotic process and thrombotic changes. A very important role in the development of the atherosclerotic process in the coronary vessels is played by the inflammatory process and the immune response. Due to the important role of lipids and the coagulation process in the atherosclerotic process, research has also focused on genes affecting lipid metabolism and the coagulation system. Lipoprotein lipase (LPL) is an enzyme that metabolises lipids, hydrolysing triglycerides to produce free fatty acids and glycerol. Protein C (PC) is an essential component of coagulation and fibrinolysis. It is activated on the endothelial surface by the membrane-bound thrombin-thrombomodulin complex. Platelet-derived growth factor (PDGF) has a number of important functions in processes related to fibroblast and smooth muscle cell function. Due to their influence on lipid metabolism and coagulation processes, LPL, PROCR (endothelial cell protein C receptor) and PDGF may affect the atherosclerotic process and, thus, the risk of coronary heart disease. The aim of the study was to examine the associations between the <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 gene polymorphisms and the risk of unstable angina and selected clinical parameters. Methods: The study included 232 patients with unstable angina and 144 healthy subjects as the control group. Genotyping was performed using real-time PCR. Results: There were no statistically significant differences in the distribution of the polymorphisms tested between the patients with unstable angina and the control subjects. The results showed associations between the <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 polymorphisms and some clinical parameters in patients with unstable angina. In patients with the <i>PDGF</i> rs974819 CC genotype, there were increased values for cholesterol and LDL serum levels in comparison with patients with the <i>PDGF</i> rs974819 CT and TT genotypes. In patients with the <i>PROCR</i> rs867186 AA genotype, HDL serum levels were lower than in patients with the GA genotype. Conclusions: The results of our study did not show that the <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 gene polymorphisms were significant risk factors for unstable angina in our population. The results of the study suggest that <i>PDGF</i> rs974819 and <i>PROCR</i> rs867186 may be associated with some parameters of lipid metabolism.
first_indexed 2024-03-07T22:24:59Z
format Article
id doaj.art-a318f00693f042aa853e58d45a1f26d8
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-07T22:24:59Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-a318f00693f042aa853e58d45a1f26d82024-02-23T15:23:52ZengMDPI AGJournal of Personalized Medicine2075-44262024-02-0114221310.3390/jpm14020213<i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable AnginaDamian Malinowski0Krzysztof Safranow1Andrzej Pawlik2Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Physiology, Pomeranian Medical University, 70-111 Szczecin, PolandBackground: Coronary artery disease is caused by changes in the coronary arteries due to the atherosclerotic process and thrombotic changes. A very important role in the development of the atherosclerotic process in the coronary vessels is played by the inflammatory process and the immune response. Due to the important role of lipids and the coagulation process in the atherosclerotic process, research has also focused on genes affecting lipid metabolism and the coagulation system. Lipoprotein lipase (LPL) is an enzyme that metabolises lipids, hydrolysing triglycerides to produce free fatty acids and glycerol. Protein C (PC) is an essential component of coagulation and fibrinolysis. It is activated on the endothelial surface by the membrane-bound thrombin-thrombomodulin complex. Platelet-derived growth factor (PDGF) has a number of important functions in processes related to fibroblast and smooth muscle cell function. Due to their influence on lipid metabolism and coagulation processes, LPL, PROCR (endothelial cell protein C receptor) and PDGF may affect the atherosclerotic process and, thus, the risk of coronary heart disease. The aim of the study was to examine the associations between the <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 gene polymorphisms and the risk of unstable angina and selected clinical parameters. Methods: The study included 232 patients with unstable angina and 144 healthy subjects as the control group. Genotyping was performed using real-time PCR. Results: There were no statistically significant differences in the distribution of the polymorphisms tested between the patients with unstable angina and the control subjects. The results showed associations between the <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 polymorphisms and some clinical parameters in patients with unstable angina. In patients with the <i>PDGF</i> rs974819 CC genotype, there were increased values for cholesterol and LDL serum levels in comparison with patients with the <i>PDGF</i> rs974819 CT and TT genotypes. In patients with the <i>PROCR</i> rs867186 AA genotype, HDL serum levels were lower than in patients with the GA genotype. Conclusions: The results of our study did not show that the <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 gene polymorphisms were significant risk factors for unstable angina in our population. The results of the study suggest that <i>PDGF</i> rs974819 and <i>PROCR</i> rs867186 may be associated with some parameters of lipid metabolism.https://www.mdpi.com/2075-4426/14/2/213LPLPROCRPDGFPolymorphismsUnstable Angina
spellingShingle Damian Malinowski
Krzysztof Safranow
Andrzej Pawlik
<i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
Journal of Personalized Medicine
LPL
PROCR
PDGF
Polymorphisms
Unstable Angina
title <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
title_full <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
title_fullStr <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
title_full_unstemmed <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
title_short <i>LPL</i> rs264, <i>PROCR</i> rs867186 and <i>PDGF</i> rs974819 Gene Polymorphisms in Patients with Unstable Angina
title_sort i lpl i rs264 i procr i rs867186 and i pdgf i rs974819 gene polymorphisms in patients with unstable angina
topic LPL
PROCR
PDGF
Polymorphisms
Unstable Angina
url https://www.mdpi.com/2075-4426/14/2/213
work_keys_str_mv AT damianmalinowski ilplirs264iprocrirs867186andipdgfirs974819genepolymorphismsinpatientswithunstableangina
AT krzysztofsafranow ilplirs264iprocrirs867186andipdgfirs974819genepolymorphismsinpatientswithunstableangina
AT andrzejpawlik ilplirs264iprocrirs867186andipdgfirs974819genepolymorphismsinpatientswithunstableangina